Stock QNRX QUOIN PHARMACEUTICALS, LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Quoin Pharmaceuticals, Ltd.

Equities

QNRX

US74907L3006

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-06-21 EDT 		5-day change 1st Jan Change
0.6124 USD -1.84% Intraday chart for Quoin Pharmaceuticals, Ltd. -10.75% -87.51%
06-06 Certain Options of Quoin Pharmaceuticals, Ltd. are subject to a Lock-Up Agreement Ending on 6-JUN-2024. CI
06-06 Certain Warrants of Quoin Pharmaceuticals, Ltd. are subject to a Lock-Up Agreement Ending on 6-JUN-2024. CI

Evolution of the average Target Price on Quoin Pharmaceuticals, Ltd.

Price target over the last 5 years

History of analyst recommendation changes

eb01fe208c7a1964f.0P1bzDoLWpYnkzL2rwXoS_wsDE8VwT0FcP-yx7DODug.j6sQv3hpbvBRqlCsnVSgfM5jdS1Sl2V_NqyDsIX7X72TpBaAUHpp2XOmXQ~a72c07b3697054a5549e6b309fd904f4

Analyst Recommendations on Quoin Pharmaceuticals, Ltd.

Maxim Group Adjusts Quoin Pharmaceuticals Price Target to $4 From $15, Maintains Buy Rating MT
JMP Securities Lowers Quoin Pharmaceuticals' Price Target to $6 From $15, Maintains Market Outperform Rating MT
Ladenburg Thalmann Downgrades Quoin Pharmaceuticals to Neutral From Buy MT
Alliance Global Partners Initiates Coverage on Quoin Pharmaceuticals With Buy Rating, $20 Price Target MT
Ladenburg Lowers Quoin Pharmaceuticals' Price Target to $12 From $25, Maintains Buy Rating MT
JMP Securities Lowers Quoin Pharmaceuticals' Price Target to $15 From $100, Maintains Outperform Rating MT
Maxim Lowers Price Target for Quoin Pharmaceuticals to $10 From $25, Maintains Buy Rating MT
Ladenburg Thalmann Starts Quoin Pharmaceuticals at Buy With $2 Price Target MT
Maxim Starts Quoin Pharmaceuticals at Buy with $5 Price Target MT
JMP Securities Starts Quoin Pharmaceuticals at Market Outperform With $8 Price Target MT
Cellect Announces Positive Results from Cell2in Collaboration Showing Significant Improvement in Expansion Rate and Function of Stem Cells CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
0.6124 USD
Average target price
5.483 USD
Spread / Average Target
+795.38%
High Price Target
10 USD
Spread / Highest target
+1,532.92%
Low Price Target
2.45 USD
Spread / Lowest Target
+300.07%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Quoin Pharmaceuticals, Ltd.

Maxim
Ladenburg Thalmann
JMP Securities
Alliance Global Partners

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. QNRX Stock
  4. Consensus Quoin Pharmaceuticals, Ltd.